is the fda going to ban compounded semaglutide issued 25 warning letters telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of 🚨 FDA Removes Compounded Semaglutide

This combination is excellent for body recomposition

Anecdotally helpful for mild nausea

The state insurer implemented coverage restrictions that aligned with the broader BCBS trend, removing weight management as a standalone covered indication

Were happy to talk and share our experience

Some patients find that establishing mental health support before starting obesity medication provides helpful continuity of care

Key Citations FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize US FDA to hold off action on weight-loss drug copies pending court ruling GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss Compound versions of GLP-1 drugs for weight loss halted by FDA FDA alerts health care providers, compounders and patients of dosing errors FDAs Semaglutide Shortage Resolution: Legal Implications and Risks US FDA to Hold off Action on Weight-Loss Drug Copies Pending Court Ruling